Chidamide Combined With Angiogenesis Inhibitors and Fulvestrant for Advanced HR-positive, HER2-negative Breast Cancer
Clinical trial NCT06750848 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06750848
- Sponsor
- Jundong Wu
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-20
- Primary completion
- 2025-12-31
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.